TCTN3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.381400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.788600E-01
Normal-vs-Stage2
9.096800E-01
Normal-vs-Stage3
7.559800E-01
Normal-vs-Stage4
4.678200E-01
Stage1-vs-Stage2
5.422400E-01
Stage1-vs-Stage3
4.345200E-01
Stage1-vs-Stage4
5.564800E-01
Stage2-vs-Stage3
4.387200E-01
Stage2-vs-Stage4
1.516240E-01
Stage3-vs-Stage4
2.956200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.708800E-01
Normal-vs-AfricanAmerican
4.765200E-01
Normal-vs-Asian
8.043200E-01
Caucasian-vs-AfricanAmerican
3.474200E-01
Caucasian-vs-Asian
4.462600E-01
AfricanAmerican-vs-Asian
1.330050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.817800E-01
Normal-vs-Female
7.783000E-01
Male-vs-Female
7.036400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.610400E-01
Normal-vs-Age(41-60Yrs)
3.917600E-01
Normal-vs-Age(61-80Yrs)
9.573000E-01
Normal-vs-Age(81-100Yrs)
9.462800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.453800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.584800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.162800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.818700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.106100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.861400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.652400E-01
Normal-vs-Daily Drinker
8.682200E-01
Normal-vs-Weekly Drinker
9.249600E-01
Normal-vs-Occasional Drinker
6.098600E-01
Normal-vs-Social Drinker
6.474600E-01
Non Drinker-vs-Daily Drinker
3.799600E-01
Non Drinker-vs-Weekly Drinker
2.119400E-01
Non Drinker-vs-Occasional Drinker
2.533800E-02
Non Drinker-vs-Social Drinker
4.186200E-02
Daily Drinker-vs-Weekly Drinker
6.275600E-01
Daily Drinker-vs-Occasional Drinker
1.579160E-01
Daily Drinker-vs-Social Drinker
2.219400E-01
Weekly Drinker-vs-Occasional Drinker
4.289800E-01
Weekly Drinker-vs-Social Drinker
5.348600E-01
Occasional Drinker-vs-Social Drinker
8.275400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.176400E-01
Normal-vs-Grade 2
5.477000E-01
Normal-vs-Grade 3
1.006030E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.687000E-01
Grade 1-vs-Grade 3
3.713400E-01
Grade 1-vs-Grade 4
2.176400E-01
Grade 2-vs-Grade 3
5.533800E-01
Grade 2-vs-Grade 4
5.477000E-01
Grade 3-vs-Grade 4
1.006030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.027600E-01
Normal-vs-NonDiabetic
9.341600E-01
Diabetic-vs-NonDiabetic
8.218200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.682800E-01
Normal-vs-NoPancreatitis
8.823800E-01
Pancreatitis-vs-NoPancreatitis
3.649400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.258200E-01
Normal-vs-N1
9.037800E-01
N0-vs-N1
4.233800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.952200E-01
Normal-vs-TP53-NonMutant
7.398800E-01
TP53-Mutant-vs-TP53-NonMutant
8.359000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
